The Use of Radiolabeled Compounds for ADME Studies in Discovery and Exploratory Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|24|2991-3008

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.24, 2004-09, pp. : 2991-3008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In-silico ADME Studies for New Drug Discovery: From Chemical Compounds to Chinese Herbal Medicines

By  

Current Drug Metabolism, Vol. 18, Iss. 6, 2017-07 ,pp. : 535-539

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled Compounds in the Development of Cytotoxic Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2923-2934

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Radiolabeled Compounds for Drug Discovery and Development (Executive Editor: Antti Jekunen)]

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Radiolabeled Compounds for Drug Discovery and Development (Executive Editor: Antti Jekunen)]

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Radiolabeled Compounds for Myocardial Perfusion Imaging

By  

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1041-1057

Bentham Science Publishers

Access to resources Recommend Favorite